arcutis
present
cantor
fitzgerald
global
healthcare
conference
westlake
village
globe
newswire
arcutis
biotherapeutics
nasdaq
arqt
biopharmaceutical
company
focused
developing
commercializing
treatments
unmet
needs
dermatological
diseases
conditions
today
announced
arcutis
management
participate
fireside
chat
presentation
cantor
fitzgerald
global
healthcare
conference
taking
place
details
presentation
follows
cantor
fitzgerald
global
healthcare
conference
presentation
date
thursday
presentation
time
pt
et
presentation
webcast
may
accessed
events
presentations
section
company
website
https
arcutis
maintain
archived
replay
webcast
website
days
conference
arcutis
bioscience
applied
skin
arcutis
biotherapeutics
nasdaq
arqt
biopharmaceutical
company
focused
developing
commercializing
treatments
unmet
needs
dermatological
diseases
conditions
company
leveraging
recent
advances
immunology
inflammation
develop
differentiated
therapies
biologically
validated
targets
solve
persistent
treatment
challenges
serious
diseases
skin
arcutis
robust
pipeline
includes
four
novel
drug
candidates
currently
development
range
inflammatory
dermatological
conditions
company
lead
product
candidate
topical
roflumilast
potential
revitalize
standard
care
plaque
psoriasis
atopic
dermatitis
scalp
psoriasis
seborrheic
dermatitis
information
visit
https
follow
company
linkedin
twitter
investors
media
heather
rowe
armstrong
vice
president
investor
relations
corporate
communications
harmstrong
ext
